ArticleFrontiers in cardiovascular medicine2022

Efficacy and safety evaluation of rivaroxaban vs. warfarin among non-valvular atrial fibrillation patients undergoing lower extremity revascularization.

Qingyuan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.